SCHEMBL6302525

SCHEMBL6302525

CCNCCCn1cccc(C(N)=O)c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 6/20 0.48
CNR1 P21554 3/20 0.48
KDM4E B2RXH2 4/20 0.45
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
BRD4 O60885 2/20 0.43
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
BRD2 P25440 1/20 0.39
BRD3 Q15059 1/20 0.39
BRDT Q58F21 1/20 0.39
RXFP1 Q9HBX9 2/20 0.39
POLB P06746 1/20 0.39
ADRA1D P25100 1/20 0.38
PARP1 P09874 1/20 0.37
PARP2 Q9UGN5 1/20 0.37
PARP3 Q9Y6F1 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6304721 0.92 KDM4E (0.47) CNR2CNR1KDM4EALDH1A1SMN1; SMN2
SCHEMBL6305637 0.82 CNR2 (0.48) CNR2CNR1KDM4EALDH1A1SMN1; SMN2
SCHEMBL16982382 0.81 CNR2 (0.54) CNR2CNR1KDM4EALDH1A1SMN1; SMN2
SCHEMBL6302526 0.80 CNR2 (0.38) CNR2CNR1KDM4EALDH1A1BRD4
SCHEMBL6302527 0.80 KDM4E (0.49) CNR2CNR1KDM4EALDH1A1SMN1; SMN2
SCHEMBL6304261 0.78 KDM4E (0.45) CNR2CNR1KDM4EALDH1A1SMN1; SMN2
SCHEMBL29820590 0.78 PARP1 (0.52) CNR2CNR1KDM4EALDH1A1SMN1; SMN2
SCHEMBL15327919 0.76 SMN1; SMN2 (0.54) CNR2CNR1KDM4EALDH1A1SMN1; SMN2
SCHEMBL20003608 0.75 ALDH1A1 (0.45) CNR2CNR1KDM4EALDH1A1SMN1; SMN2
SCHEMBL6302792 0.75 KDM4E (0.47) CNR2CNR1KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949562-B2 Heterocyclic compounds as ligands of the GABAA receptor NEUROGEN CORPORATION (US) 2005-09-27 US disclosed